课题基金 / 基金详情

NOVEL POU PROTEIN AND LYMPHOCYTE GENE EXPRESSION

NOVEL POU PROTEIN AND LYMPHOCYTE GENE EXPRESSION
新型 POU 蛋白和淋巴细胞基因表达
批准号:
2886707
负责人:
ARUN FOTEDAR
金额:
$32.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-08-01 至 2001-07-31

项目摘要

项目成果

ARUN FOTEDAR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Unraveling the underlying molecular mechanisms which regulate the lymphoid phenotype and lymphoid maturation is crucial for our understanding of immune function. POU domain proteins have been found to be critical for development and maintenance of the mature phenotype of specific lineages. POU proteins affect development be regulating lineage specific gene expression via athe octamer or octamer related motifs. Mutation of POU genes affects this interaction and leads to aberrations in development of specific lineages. The importance of octamer and octamer like motifs in lymphocyte specific gene expression is well documented. The known lymphoid POU proteins can not satisfactorily explain most of the octamer dependent lymphoid specific gene expression. We have identified a novel lymphoid POU protein, TCFbeta1 which is distantly related to other known POU proteins. We propose here experiments designed to reveal its function in mature lymphoid cells and during T cell development. This will involve determining the effect of abrogation of TCFbeta1 activity on the lymphoid phenotype. In particular studies are described which address its role in regulating the Calcium sensitive signaling pathway in Il2 gene expression. We will also be involved with abrogate TCFbeta1 activity in thymus of transgenic mice in order to understand athe role of TCFbeta1 in T cell development. They will clarify the comparative roles of three different lymphoid POU domain proteins in T cell development. These studies will help generate tissue culture and mouse models of immune dysfunction which help in elucidating lymphocyte development and function.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/s0764-4469(99)80032-8
发表时间: 1999
期刊: Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie
影响因子: --
作者: [Salles-Passador,I, Fotedar,A, Fotedar,R]
通讯作者: Fotedar,R
DOI: --
发表时间: 2000-04
期刊: Pathologie-biologie
影响因子: --
作者: [J. Boulaire;A. Fotedar;R. Fotedar]
通讯作者: J. Boulaire;A. Fotedar;R. Fotedar
p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
p21 包含细胞周期蛋白和 cdk2 的独立结合位点:这两个位点都是抑制 cdk2 激酶活性所必需的。
DOI: --
发表时间: 1996
期刊: Oncogene
影响因子: 8
作者: [Fotedar,R, Fitzgerald,P, Rousselle,T, Cannella,D, Doree,M, Messier,H, Fotedar,A]
通讯作者: Fotedar,A
UV and p21 Degradation
  • 批准号:
    7078605
  • 项目类别:
  • 资助金额:
    $33.5万
  • 财政年份:
    2005
  • 负责人:
    ARUN FOTEDAR
  • 依托单位:
UV and p21 Degradation
  • 批准号:
    6930037
  • 项目类别:
  • 资助金额:
    $34.42万
  • 财政年份:
    2005
  • 负责人:
    ARUN FOTEDAR
  • 依托单位:
Role of WISp39 and Ubiquitination in p21 Function
  • 批准号:
    7033099
  • 项目类别:
  • 资助金额:
    $33.56万
  • 财政年份:
    2004
  • 负责人:
    ARUN FOTEDAR
  • 依托单位:
Role of WISp39 and Ubiquitination in p21 Function
  • 批准号:
    6775035
  • 项目类别:
  • 资助金额:
    $34.37万
  • 财政年份:
    2004
  • 负责人:
    ARUN FOTEDAR
  • 依托单位:
海外基金